Inimmune Receives $1M SBIR Phase II Grant

Inimmune Receives $1M SBIR Phase II Grant

Oct 16, 2019 | News

Montana biotech company receives Small Business Innovation Research Grant to develop novel treatments against infectious diseases. Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded $1,017,317 from the National Institute for...